- Filed
- Nov 15, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2024 · Nov 11, 2024 | 27.09M sh |
| Cash And Equivalents | FY 2024 · Sep 30, 2023 | $256.23M |
| Current Liabilities | FY 2024 · Sep 30, 2023 | $1.81B |
| Total Liabilities | FY 2024 · Sep 30, 2023 | $2.11B |
| Current Assets | FY 2024 · Sep 30, 2023 | $2.67B |
| Total Assets | FY 2024 · Sep 30, 2023 | $3.32B |
| Shares Diluted | FY 2024 · Oct 1, 2022 | 28.44M sh |
| Stock Repurchased | FY 2024 · Oct 1, 2022 | $50.39M |
| Capex | FY 2024 · Oct 1, 2022 | $101.61M |
| Operating Cash Flow | FY 2024 · Oct 1, 2022 | −$26.24M |
| Eps Diluted | FY 2024 · Oct 1, 2022 | $4.86 |
| Eps Basic | FY 2024 · Oct 1, 2022 | $4.96 |
| Sga Expense | FY 2024 · Oct 1, 2022 | $167.02M |
| Net Income | FY 2024 · Oct 1, 2022 | $138.24M |
| Operating Income | FY 2024 · Oct 1, 2022 | $178.19M |
| Gross Profit | FY 2024 · Oct 1, 2022 | $347.23M |
| Cost Of Revenue | FY 2024 · Oct 1, 2022 | $3.46B |
| Revenue restated | FY 2024 · Oct 1, 2022 | $3.93B |
| Stockholders Equity | FY 2024 · Oct 2, 2021 | $1.03B |